Health Care & Life Sciences » Pharmaceuticals | Premier Biomedical Inc.

Premier Biomedical Inc.

Premier Biomedical Inc.
Stock Exchange Other OTC
EPS
$0.22
Market Cap
$130.21 K
Shares Outstanding
9.72 M
Public Float
4.52 M

Profile

Address
PO Box 25
Jackson Center Pennsylvania 16133
United States
Employees -
Website http://www.premierbiomedical.com
Updated 07/08/2019
Premier Biomedical, Inc. is a research-based company, which engages in the development and marketing of medications and procedures. It intends to discover and develop medical treatments for humans, specifically targeting the treatment of alzheimer's disease, fibromyalgia, multiple sclerosis, traumatic brain injury, amyotrophic lateral sclerosis, blood sepsis and viremia, and cancer. The company was founded by Mitchell S.

Financials

View All

Mitchell S. Felder
Chairman
William A. Hartman
President, Chief Executive Officer & Director